Drug Side Effects
Search
MARSTACIMAB-HNCQ
MARSTACIMAB-HNCQ
was reported 103 times
These side effects are most commonly reported by patients taking MARSTACIMAB-HNCQ:
#
Side effect
Count
0
HAEMARTHROSIS
21
1
HAEMORRHAGE
18
2
DRUG DOSE OMISSION BY DEVICE
9
3
DEVICE DEFECTIVE
7
4
DEVICE FAILURE
6
5
EPISTAXIS
6
6
CONTUSION
5
7
ARTHRALGIA
4
8
DEVICE MALFUNCTION
4
9
DRUG INEFFECTIVE
4
10
JOINT SWELLING
4
11
PRODUCT DOSE OMISSION ISSUE
4
12
TRANSIENT ISCHAEMIC ATTACK
4
13
TRAUMATIC HAEMORRHAGE
4
14
DEVICE MECHANICAL ISSUE
3
15
FALL
3
16
SUSPECTED OFF LABEL USE
3
17
SWELLING
3
18
ALANINE AMINOTRANSFERASE INCREASED
2
19
ASPARTATE AMINOTRANSFERASE INCREASED
2
20
BLINDNESS UNILATERAL
2
21
BRAIN FOG
2
22
CHEST PAIN
2
23
DEVICE BREAKAGE
2
24
DEVICE DELIVERY SYSTEM ISSUE
2
25
DEVICE DEPLOYMENT ISSUE
2
26
DEVICE LEAKAGE
2
27
FRACTURE
2
28
HAEMATURIA
2
29
HYPOAESTHESIA
2
30
INJECTION SITE PAIN
2
31
INJECTION SITE SWELLING
2
32
INJURY
2
33
JOINT MICROHAEMORRHAGE
2
34
LIMB INJURY
2
35
LOWER LIMB FRACTURE
2
36
MUSCLE HAEMORRHAGE
2
37
MUSCLE SPASMS
2
38
NECK PAIN
2
39
NEPHROLITHIASIS
2
40
OFF LABEL USE
2
41
PAIN
2
42
PAIN IN EXTREMITY
2
43
SPONTANEOUS HAEMORRHAGE
2
44
URTICARIA
2
45
ABDOMINAL DISCOMFORT
1
46
ABDOMINAL PAIN
1
47
ABDOMINAL PAIN UPPER
1
48
ACCIDENTAL EXPOSURE TO PRODUCT
1
49
ACUTE KIDNEY INJURY
1
50
ACUTE MYOCARDIAL INFARCTION
1
51
ANAEMIA
1
52
ATRIAL FIBRILLATION
1
53
BLINDNESS
1
54
BLOOD POTASSIUM DECREASED
1
55
BLOOD PRESSURE INCREASED
1
56
BONE DISORDER
1
57
CENTRAL VENOUS CATHETER REMOVAL
1
58
CEREBRAL HAEMORRHAGE
1
59
CEREBROVASCULAR ACCIDENT
1
60
CONDITION AGGRAVATED
1
61
CONFUSIONAL STATE
1
62
DEEP VEIN THROMBOSIS
1
63
DEVICE OCCLUSION
1
64
DEVICE OPERATIONAL ISSUE
1
65
DEVICE PHYSICAL PROPERTY ISSUE
1
66
DIARRHOEA
1
67
DISTURBANCE IN ATTENTION
1
68
DIZZINESS
1
69
DYSARTHRIA
1
70
ERECTILE DYSFUNCTION
1
71
EXTRA DOSE ADMINISTERED
1
72
FATIGUE
1
73
FEELING ABNORMAL
1
74
FEELING HOT
1
75
FIBRIN D DIMER INCREASED
1
76
GASTROINTESTINAL DISORDER
1
77
GENERAL PHYSICAL HEALTH DETERIORATION
1
78
GINGIVAL BLEEDING
1
79
HAEMOPHILIA
1
80
HAEMORRHAGE URINARY TRACT
1
81
HEAD INJURY
1
82
HEADACHE
1
83
HOSPITALISATION
1
84
HYPERSENSITIVITY
1
85
IMPAIRED GASTRIC EMPTYING
1
86
INCORRECT DOSE ADMINISTERED
1
87
INCORRECT DOSE ADMINISTERED BY DEVICE
1
88
INFECTION
1
89
INFLUENZA
1
90
INJECTION SITE BRUISING
1
91
INJECTION SITE DISCHARGE
1
92
INJECTION SITE HAEMORRHAGE
1
93
INJECTION SITE HYPERSENSITIVITY
1
94
INJECTION SITE REACTION
1
95
INJURY ASSOCIATED WITH DEVICE
1
96
INTERMENSTRUAL BLEEDING
1
97
INTERNAL HAEMORRHAGE
1
98
KNEE OPERATION
1
99
MYOCARDIAL INFARCTION
1
100
NASOPHARYNGITIS
1
101
NEEDLE ISSUE
1
102
NO ADVERSE EVENT
1
103
OCCUPATIONAL EXPOSURE TO PRODUCT
1
104
PARAESTHESIA
1
105
PELVIC PAIN
1
106
PERIPROSTHETIC FRACTURE
1
107
POOR VENOUS ACCESS
1
108
PRODUCT USE ISSUE
1
109
PROTHROMBIN FRAGMENT 1.2 INCREASED
1
110
PRURITUS
1
111
SKIN HAEMORRHAGE
1
112
SKIN LACERATION
1
113
SLEEP TERROR
1
114
SOFT TISSUE HAEMORRHAGE
1
115
SPEECH DISORDER
1
116
THROAT TIGHTNESS
1
117
THROMBOTIC STROKE
1
118
TREATMENT FAILURE
1
119
TREMOR
1
120
TUNNEL VISION
1
121
UNDERDOSE
1
122
UPPER LIMB FRACTURE
1
123
URINARY TRACT INFECTION
1
124
VISION BLURRED
1
125
VISUAL IMPAIRMENT
1
126
VOMITING
1
127
WOUND INFECTION
1
128
WRIST SURGERY
1
129
WRONG TECHNIQUE IN DEVICE USAGE PROCESS
1